BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16835384)

  • 21. Chemoprotection against cytosine nucleoside analogs using the human cytidine deaminase gene.
    Eliopoulos N; Beauséjour C; Momparler RL
    Prog Exp Tumor Res; 1999; 36():124-42. PubMed ID: 10386070
    [No Abstract]   [Full Text] [Related]  

  • 22. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J
    Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new technique for the analysis of metabolic pathways of cytidine analogues and cytidine deaminase activities in cells.
    Ligasová A; Piskláková B; Friedecký D; Koberna K
    Sci Rep; 2023 Nov; 13(1):20530. PubMed ID: 37993628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo.
    Yoshida T; Endo Y; Obata T; Kosugi Y; Sakamoto K; Sasaki T
    Drug Metab Dispos; 2010 Oct; 38(10):1814-9. PubMed ID: 20587622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cytidine deaminase expressed in the post-infective L3 stage of the filarial nematode, Brugia pahangi, has a novel RNA-binding activity.
    Anant S; Martin SA; Yu H; MacGinnitie AJ; Devaney E; Davidson NO
    Mol Biochem Parasitol; 1997 Sep; 88(1-2):105-14. PubMed ID: 9274872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.
    Gourdeau H; Clarke ML; Ouellet F; Mowles D; Selner M; Richard A; Lee N; Mackey JR; Young JD; Jolivet J; Lafrenière RG; Cass CE
    Cancer Res; 2001 Oct; 61(19):7217-24. PubMed ID: 11585758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
    Schröder JK; Kirch C; Flasshove M; Kalweit H; Seidelmann M; Hilger R; Seeber S; Schütte J
    Leukemia; 1996 Dec; 10(12):1919-24. PubMed ID: 8946931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tightly regulated 'all-in-one' lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy.
    Lachmann N; Brennig S; Hillje R; Schermeier H; Phaltane R; Dahlmann J; Gruh I; Heinz N; Schiedlmeier B; Baum C; Moritz T
    Gene Ther; 2015 Nov; 22(11):883-92. PubMed ID: 26125609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lethal toxicity after administration of azacytidine: implication of the cytidine deaminase-deficiency syndrome.
    Fanciullino R; Mercier C; Serdjebi C; Berda Y; Fina F; Ouafik L; Lacarelle B; Ciccolini J; Costello R
    Pharmacogenet Genomics; 2015 Jun; 25(6):317-21. PubMed ID: 25850965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.
    Sauerbrey A; McPherson JP; Zhao SC; Banerjee D; Bertino JR
    Hum Gene Ther; 1999 Oct; 10(15):2495-504. PubMed ID: 10543614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
    Mejer J; Mortensen BT
    Adv Exp Med Biol; 1989; 253B():335-9. PubMed ID: 2558539
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacogenomics of gemcitabine metabolism: functional analysis of genetic variants in cytidine deaminase and deoxycytidine kinase.
    Baker JA; Wickremsinhe ER; Li CH; Oluyedun OA; Dantzig AH; Hall SD; Qian YW; Ring BJ; Wrighton SA; Guo Y
    Drug Metab Dispos; 2013 Mar; 41(3):541-5. PubMed ID: 23230131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A murine model for human cord blood transplantation: near-term fetal and neonatal peripheral blood cells can achieve long-term bone marrow engraftment in sublethally irradiated adult recipients.
    Scaradavou A; Isola L; Rubinstein P; Galperin Y; Najfeld V; Berlin D; Gordon J; Weinberg RS
    Blood; 1997 Feb; 89(3):1089-99. PubMed ID: 9028342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional analysis of the cytidine deaminase gene in patients with acute myeloid leukaemia.
    Schröder JK; Kirch C; Seeber S; Schütte J
    Br J Haematol; 1998 Dec; 103(4):1096-103. PubMed ID: 9886326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM; Le NL; Létourneau S; Cournoyer D; Momparler RL
    Hum Gene Ther; 1998 Nov; 9(17):2537-44. PubMed ID: 9853520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.
    Shord SS; Patel SR
    J Exp Clin Cancer Res; 2009 Jun; 28(1):76. PubMed ID: 19500405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.
    Budak-Alpdogan T; Alpdogan O; Banerjee D; Wang E; Moore MA; Bertino JR
    Mol Ther; 2004 Sep; 10(3):574-84. PubMed ID: 15336657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene amplification of human cytidine deaminase proviral cDNA and increased levels of its mRNA produces enhanced drug resistance to cytosine arabinoside in retroviral-transduced murine fibroblasts.
    Beauséjour CM; Momparler RL
    Cancer Lett; 1999 Jan; 135(1):29-36. PubMed ID: 10077218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
    Jansen M; Sorg UR; Ragg S; Flasshove M; Seeber S; Williams DA; Moritz T
    Cancer Gene Ther; 2002 Sep; 9(9):737-46. PubMed ID: 12189523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.